提问
问诊
发现
计算
注册
注册
登录
登录
发现
FDA Approves Fam-Trastuzumab Deruxtecan-Nxki Plus Pertuzumab for First-Line Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer - Vera Health News